"Individualise devices to cut Spanish HCV (hospital-acquired hepatitis C) rates":
This article was originally published in Clinica
Spanish hepatologists are calling for all instruments used to explore patients to be "individualised", in order to reduce the incidence of hospital-acquired hepatitis C (HCV) infections, according to El Pais. This is one of the recommendations to emerge from a study by the hepatology unit of Barcelona's Hospital Clinic, which found a 0.27% infection rate (Hepatology, January 2005). This could easily be reduced further if appropriate precautions were implemented, the authors concluded.
You may also be interested in...
Revised bill released by the US Senate Finance Committee adjusts the manufacturer discount program in Medicare Part D and includes new provisions aimed at easing beneficiary cost sharing obligations.
Through a draft guidance, the US agency has established performance criteria for magnetic resonance coils, making the devices eligible for the standards-based Safety and Performance Based Pathway.
Singapore recalls trigger international reaction as metformin is added to growing list of chronic medications found to contain NDMA.